Deactivation of the canonical Wnt/beta-catenin pathway and activation of PPAR gamma are also observed in arrhythmogenic right ventricular cardiomyopathy (ARVC) (1, 41). This evidence concerns the gene CTNNB1 and arrhythmogenic right ventricular cardiomyopathy.